WithdrawnNot applicableNCT01663090

Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dana-Farber Cancer Institute
Principal Investigator
Allison O'Neill, MD
Dana-Farber Cancer Institute
Intervention
Ferumoxytol(drug)
Eligibility
12 years · All sexes
Timeline
2012 – 2016

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01663090 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma →

← Back to all trials